Mineralys Therapeutics Inc — 財務諸表 (NASDAQ:MLYS) | MetaTrader

チャート全体を表示

ニュース

Jefferies、薬剤懸念でMineralys Therapeuticsの目標株価を引き下げ

Jefferies cuts Mineralys Therapeutics price target on drug concerns

Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS)

Stifel、Mineralys株にBuy評価を再確認、目標株価52ドル

Stifel reiterates Buy rating on Mineralys stock, $52 target

BofAがMineralys Therapeuticsの目標株価を引き上げ、NDA進展を評価

BofA raises Mineralys Therapeutics stock price target on NDA progress

Mineralys Therapeutics, Inc. (MLYS) Q4 2025 Earnings Call Transcript

FDA承認判断を控えMineralysの決算に注目集まる

Mineralys earnings in focus as FDA lorundrostat decision looms

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Stifel、Mineralys Therapeuticsの株式レーティングをlorundrostatデータで再確認